m+Medelevator.RU
← Поиск публикаций
Human vaccines & immunotherapeutics · 2016

Invasive pneumococcal disease: From a tertiary care hospital in the post-vaccine era.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Tanır Basaranoglu Sevgen, Karadag Oncel Eda, Aykac Kubra, Ozsurekci Yasemin, Cengiz Ali Bülent, Kara Ates, Ceyhan Mehmet

Аннотация

A breakthrough infection occurring with 13-valent pneumococcal conjugate vaccine (PCV13) in Turkey are previously described. A breakthrough infection is defined as IPD in a child who had received ≥ 1 PCV-7 or PCV-13 and for which the pneumococcal isolate was a vaccine serotype. During one year period, among 6 patients with invasive pneumococcal infection, 2 patients were considered to have a vaccine failure with serotype 19F. Antibiotic resistance results were remarkable; macrolide resistance were observed in all strains except one, and high and intermediate penicillin resistance were determined in 2 strains.

Предметные рубрики MeSH